Cargando…
Epidemiology of Pain Among Patients with Solid Metastatic Cancer During the Last Year of Life
BACKGROUND: Despite medical advancements, pain is a major source of suffering at the end of life for patients with a solid metastatic cancer. We aimed to assess the trajectory of pain prevalence, severity, interference, and inadequacy of analgesia during the last year of life. METHODS: We analysed d...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488613/ https://www.ncbi.nlm.nih.gov/pubmed/36147456 http://dx.doi.org/10.2147/JPR.S375874 |
_version_ | 1784792697362448384 |
---|---|
author | Chaudhry, Isha Shafiq, Mahham Teo, Irene Ozdemir, Semra Malhotra, Chetna |
author_facet | Chaudhry, Isha Shafiq, Mahham Teo, Irene Ozdemir, Semra Malhotra, Chetna |
author_sort | Chaudhry, Isha |
collection | PubMed |
description | BACKGROUND: Despite medical advancements, pain is a major source of suffering at the end of life for patients with a solid metastatic cancer. We aimed to assess the trajectory of pain prevalence, severity, interference, and inadequacy of analgesia during the last year of life. METHODS: We analysed data from the last year of life of 345 decedents from a prospective cohort study of 600 patients with a solid metastatic cancer in Singapore. Patients were surveyed every 3 months and their pain outcomes (prevalence, severity, and interference) and inadequacy of analgesia were analysed. We used mixed-effects regressions to assess the association of pain outcomes with patients’ time from death, demographics, and planned or unplanned hospitalisations. RESULTS: Prevalence of pain was higher in the last 2 months (65%) compared to 11 to 12 months (41%) before death. Pain severity and interference scores (mean ± SD) were also higher in the last month (severity: 2.5±2.6; interference: 2.6±3.0) compared to 12 months before death (severity: 1.4±2.0; interference: 1.4±2.0). At any time during the last year of life, 38% of the patients were prescribed non-steroidal anti-inflammatory drugs, 11% were prescribed weak-opioids and 29% were prescribed strong opioids. These analgesics were prescribed through either oral, topical or injectable route. Pain outcomes were significantly worse (p-value<0.05) for younger patients, those with higher education, and more financial difficulties, while interference was higher after an unplanned hospitalisation in the last month. Females reported higher pain severity score during their last year of life compared to males. For patients reporting moderate to severe pain, inadequacy of analgesia was lower in the last 2 months (43%) compared to 11 to 12 months before death (83%). CONCLUSION: Findings highlight the need for greater attention in monitoring and treatment of pain even earlier in the disease trajectory, and increased attention to patients discharged from an unplanned hospitalisation. |
format | Online Article Text |
id | pubmed-9488613 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-94886132022-09-21 Epidemiology of Pain Among Patients with Solid Metastatic Cancer During the Last Year of Life Chaudhry, Isha Shafiq, Mahham Teo, Irene Ozdemir, Semra Malhotra, Chetna J Pain Res Short Report BACKGROUND: Despite medical advancements, pain is a major source of suffering at the end of life for patients with a solid metastatic cancer. We aimed to assess the trajectory of pain prevalence, severity, interference, and inadequacy of analgesia during the last year of life. METHODS: We analysed data from the last year of life of 345 decedents from a prospective cohort study of 600 patients with a solid metastatic cancer in Singapore. Patients were surveyed every 3 months and their pain outcomes (prevalence, severity, and interference) and inadequacy of analgesia were analysed. We used mixed-effects regressions to assess the association of pain outcomes with patients’ time from death, demographics, and planned or unplanned hospitalisations. RESULTS: Prevalence of pain was higher in the last 2 months (65%) compared to 11 to 12 months (41%) before death. Pain severity and interference scores (mean ± SD) were also higher in the last month (severity: 2.5±2.6; interference: 2.6±3.0) compared to 12 months before death (severity: 1.4±2.0; interference: 1.4±2.0). At any time during the last year of life, 38% of the patients were prescribed non-steroidal anti-inflammatory drugs, 11% were prescribed weak-opioids and 29% were prescribed strong opioids. These analgesics were prescribed through either oral, topical or injectable route. Pain outcomes were significantly worse (p-value<0.05) for younger patients, those with higher education, and more financial difficulties, while interference was higher after an unplanned hospitalisation in the last month. Females reported higher pain severity score during their last year of life compared to males. For patients reporting moderate to severe pain, inadequacy of analgesia was lower in the last 2 months (43%) compared to 11 to 12 months before death (83%). CONCLUSION: Findings highlight the need for greater attention in monitoring and treatment of pain even earlier in the disease trajectory, and increased attention to patients discharged from an unplanned hospitalisation. Dove 2022-09-16 /pmc/articles/PMC9488613/ /pubmed/36147456 http://dx.doi.org/10.2147/JPR.S375874 Text en © 2022 Chaudhry et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Short Report Chaudhry, Isha Shafiq, Mahham Teo, Irene Ozdemir, Semra Malhotra, Chetna Epidemiology of Pain Among Patients with Solid Metastatic Cancer During the Last Year of Life |
title | Epidemiology of Pain Among Patients with Solid Metastatic Cancer During the Last Year of Life |
title_full | Epidemiology of Pain Among Patients with Solid Metastatic Cancer During the Last Year of Life |
title_fullStr | Epidemiology of Pain Among Patients with Solid Metastatic Cancer During the Last Year of Life |
title_full_unstemmed | Epidemiology of Pain Among Patients with Solid Metastatic Cancer During the Last Year of Life |
title_short | Epidemiology of Pain Among Patients with Solid Metastatic Cancer During the Last Year of Life |
title_sort | epidemiology of pain among patients with solid metastatic cancer during the last year of life |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488613/ https://www.ncbi.nlm.nih.gov/pubmed/36147456 http://dx.doi.org/10.2147/JPR.S375874 |
work_keys_str_mv | AT chaudhryisha epidemiologyofpainamongpatientswithsolidmetastaticcancerduringthelastyearoflife AT shafiqmahham epidemiologyofpainamongpatientswithsolidmetastaticcancerduringthelastyearoflife AT teoirene epidemiologyofpainamongpatientswithsolidmetastaticcancerduringthelastyearoflife AT ozdemirsemra epidemiologyofpainamongpatientswithsolidmetastaticcancerduringthelastyearoflife AT malhotrachetna epidemiologyofpainamongpatientswithsolidmetastaticcancerduringthelastyearoflife AT epidemiologyofpainamongpatientswithsolidmetastaticcancerduringthelastyearoflife |